OncoSec Medical Inc (ONCSQ)

[$Moneypenny$]

I really think we are going to get a partnership announcement with Merck this Sunday at AACR. A couple of reasons:

1. This conference is sponsored by Merck.
2. It is in ONCS' backyard (San Diego).
3. The title is "Antitumor activity of the anti-PD-1 monoclonal antibody MK-3475 in melanoma(MEL): Correlation of tumor PD-L1 expression with outcome" where Daud is the lead presenter but it also is co-sponsored UCSF and UCLA, both the research hospitals that ONCS has worked with. Further, the drug is a Merck drug. Why would Daud be the lead presenter for a Merck drug unless it is tied with ONCS somehow?
4. The title of the session is "Novel Immune and Targeted Therapies for Hematologic Malignancies and Solid Tumors." This would definitely be "novel" and an awesome presentation.
5. Punit went to Boston for "face-to-face" meetings recently right after a partnership conference (Sachs).
6. This follows the same pattern of major news that ONCS has done before. The intern data for melanoma was presented at a scientific conference that was given on Sunday (by Daud) in which there was no press release before the conference. A press release with the data was released by ONCS the following day (Monday).

Of course, I might be wrong, but anybody that sells shares today is an idiot. GLTA.